Track topics on Twitter Track topics that are important to you
European regulators have granted CE mark approval for Embolx's next-generation Sniper balloon occlusion microcatheters for tr -More-
Embolx's Sniper balloon occlusion microcatheter has been granted 510(k) clearance by the FDA. -More-
Medical devices maker Embolx has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its next generation Sniper balloon occlusion microcatheter for pressure-directed arterial e...
The National Cancer Institute (NCI) of the National Institutes of Health (NIH) has awarded Embolx a Small Business Innovation Research (SBIR) grant valued at $2m for further development of pressure-d...
Available both in the US and Europe, the microcatheters feature a system to deliver pressure-directed arterial embolization therapy. Sniper microcatheters will enhance the therapeutic agent delivery t...
Embolx, Inc., a medical device company, announced today that the Company has received a Federal Supply Schedule contract from the U.S. Department of Veterans Affairs (VA) t...
Next-Generation Balloon Microcatheters Now Commercially Available in Europe Embolx, Inc., a medical device company developing microcatheters for arterial emboliz...
Embolx, Inc., a medical device company, announced today that the Company has been awarded a Small Business Innovation Research (SBIR) grant valued at $2 million from the Na...
Embolx is an emerging commercial-stage medical device company in Silicon Valley developing microcatheters for arterial embolization procedures. Embolx is committed to dramatically...
We have published hundreds of Embolx, Inc. news stories on BioPortfolio along with dozens of Embolx, Inc. Clinical Trials and PubMed Articles about Embolx, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Embolx, Inc. Companies in our database. You can also find out about relevant Embolx, Inc. Drugs and Medications on this site too.
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...
Benign Prostatic Hyperplasia (BPH)
An enlarged prostate (benign prostatic enlargement (BPE) or benign prostatic hyperplasia (BPH)) is common in men after the age of about 50. Having an enlarged prostate does not mean you have cancer. In some cases, an enlarged prostate can cause the ...